PRPONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Precipio, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$21.89+0.52 (+2.41%)

Close on Oct 19, 2026

Market cap: $39.12M
P/E (TTM): –
Dividend yield: –

Dividends

Precipio has not reported a dividend

No dividend per share appears in Precipio's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Precipio's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Sep 22, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRPO.

Revenue growth28.0% · median 10.0%

Gross margin44.1% · median 52.8%

Operating margin-5.7% · median -99.6%

Net margin-1.3% · median -80.2%

Company	Revenue	Growth
QTRX	$153.41M	+22.0%
HBIO	$87.81M	-1.1%
IDXG	$36.14M	-20.5%
RPID	$35.18M	+16.1%
BNGO	$30.18M	+10.0%
PRPO	$27.20M	+28.0%

Company

Exchange: Nasdaq
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 31
Employees: 61
Held by institutions: 8.8%
Auditor: CBIZ CPAs P.C.
SEC CIK: 1043961

Advertisement
300 × 250